Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 12/20 | 0.40 |
| ▸ | MMP2 | P08253 | 12/20 | 0.40 |
| ▸ | MMP9 | P14780 | 12/20 | 0.40 |
| ▸ | MMP8 | P22894 | 12/20 | 0.40 |
| ▸ | MMP13 | P45452 | 12/20 | 0.40 |
| ▸ | CA2 | P00918 | 11/20 | 0.40 |
| ▸ | CA1 | P00915 | 8/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL7972093 | 1.00 | MMP1 (0.40) | MMP1MMP2MMP9MMP8MMP13 | |
| Potassium Ion SCHEMBL7968724 | 1.00 | MMP1 (0.40) | MMP1MMP2MMP9MMP8MMP13 | |
| Potassium Ion SCHEMBL7966881 | 1.00 | MMP1 (0.40) | MMP1MMP2MMP9MMP8MMP13 | |
| Potassium Ion SCHEMBL7966004 | 0.98 | MMP1 (0.41) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL25246586 | 0.97 | MMP1 (0.40) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL6880862 | 0.97 | MMP1 (0.40) | MMP1MMP2MMP9MMP8MMP13 | |
| Potassium Ion SCHEMBL4154859 | 0.88 | MMP1 (0.39) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL8773070 | 0.85 | MMP1 (0.39) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL7971831 | 0.84 | MMP1 (0.45) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL6340658 | 0.84 | MMP1 (0.45) | MMP1MMP2MMP9MMP8MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119445434-A | Frame supervision video instance segmentation system with timing sequence characteristics fused | 重庆位图信息技术有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119028595-A | Method for building open domain adaptive Alzheimer disease diagnosis model | 重庆理工大学 | 2024-11-26 | — | — | CN | claimed |
| EP-4413969-A1 | DISPERSION AND PREPARATION WITH CINEOL FOR TOPICAL USE | Cineolux GmbH (DE) | 2024-08-14 | — | — | EP | claimed |
| US-12630729-B2 | Ink, printing apparatus, printing method, and printed matter | RICOH COMPANY, LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| CN-117203062-B | Contact member, drying apparatus and printing apparatus | 株式会社理光 | 2026-05-12 | — | — | CN | disclosed |
| US-20260088352-A1 | Heterocyclic Electrolyte Additives for Rechargeable Metal Batteries | U S ARMY DEVCOM ARMY RES LABORATORY (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4328248-B1 | ULTRAVIOLET-CURABLE WATER-BASED INK, DISPERSION, ULTRAVIOLET-CURABLE WATER-BASED COMPOSITION AND PRINTED MATTER | MITSUBISHI CHEM CORP (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-12578665-B2 | Toner producing method | RICOH COMPANY, LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| EP-4703438-A1 | ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER | Mitsubishi Chemical Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703437-A1 | ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER | Mitsubishi Chemical Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| CN-121582626-A | Unmanned aerial vehicle target recognition method and device based on track anomaly detection | 中国人民解放军军事科学院军事医学研究院 | 2026-02-27 | — | — | CN | disclosed |
| US-4859570-A | Photosensitive element having improved antistatic layer | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-08-22 | — | — | US | disclosed |
| US-4837135-A | SPUTTERED LAYER OF INDIUM-TIN OXIDE AND CHROMIUM CROSSLINKED SILVER HALIDE GELATIN EMULSION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-06-06 | — | — | US | disclosed |
| EP-0303503-A2 | Electron beam recording film | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-02-15 | — | — | EP | disclosed |
| EP-0300376-A1 | Element having improved antistatic layer | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-01-25 | — | — | EP | disclosed |
| US-4778915-A | WATER REPELLANT, OIL REPELLANT PROTECTIVE COATINGS FOR LEATHER | ATOCHEM (FR) | 1988-10-18 | — | — | US | disclosed |
| US-4472286-A | FOAMING AGENTS FOR FIRE-FIGHTING | CIBA-GEIGY CORPORATION (US) | 1984-09-18 | — | — | US | disclosed |
| US-4420434-A | WETTING AGENTS; FIRE EXTINGUISHERS; NONHYDROLYZING AMINE SALT OF CATIONIC AND ANIONIC SURFACTANT | CIBA-GEIGY CORPORATION (US) | 1983-12-13 | — | — | US | disclosed |
| US-4299749-A | STABLE, AQUEOUS, SELF-STRIPPING FLOOR CLEANER | STERLING DRUG INC. (US) | 1981-11-10 | — | — | US | disclosed |
| US-4032495-A | WATER-REPELLENT AND OIL-REPELLENT COMPOSITIONS BASED ON FLUORINE COMPOUND | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1977-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260088352-A1 | Heterocyclic Electrolyte Additives for Rechargeable Metal Batteries | CA3, CA1, HCN1 | MMP1 2058/4885MMP2 1865/4885MMP9 2029/4885 |
| US-12578665-B2 | Toner producing method | HEATR1, KDELR1, H1-0 | MMP1 3000/4885MMP2 4158/4885MMP9 4701/4885 |
| US-12630729-B2 | Ink, printing apparatus, printing method, and printed matter | RHOC, TMCO1, MAP1LC3C | MMP1 279/4885MMP2 1073/4885MMP9 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.